Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice

The insulin-like growth factors (IGFs) are essential for development; bioavailable IGF is tightly regulated by six related IGF-binding proteins (IGFBPs). Igfbp5 is the most conserved and is developmentally up-regulated in key lineages and pathologies; in vitro studies suggest that IGFBP-5 functions independently of IGF interaction. Genetic ablation of individual Igfbps has yielded limited phenotypes because of substantial compensation by remaining family members. Therefore, to reveal Igfbp5 actions in vivo, we generated lines of transgenic mice that ubiquitously overexpressed Igfbp5 from early development. Significantly increased neonatal mortality, reduced female fertility, whole-body growth inhibition, and retarded muscle development were observed in Igfbp5-overexpressing mice. The magnitude of the response in individual transgenic lines was positively correlated with Igfbp5 expression. Circulating IGFBP-5 concentrations increased a maximum of only 4-fold, total and free IGF-I concentrations increased up to 2-fold, and IGFBP-5 was detected in high Mr complexes; however, no detectable decrease in the proportion of free IGF-I was observed. Thus, despite only modest changes in IGF and IGFBP concentrations, the Igfbp5-overexpressing mice displayed a phenotype more extreme than that observed for other Igfbp genetic models. Although growth retardation was obvious prenatally, maximal inhibition occurred postnatally before the onset of growth hormone-dependent growth, regardless of Igfbp5 expression level, revealing a period of sensitivity to IGFBP-5 during this important stage of tissue programming.

[1]  R. Baxter,et al.  Insulin-like Growth Factor-binding Protein-5 Inhibits the Growth of Human Breast Cancer Cells in Vitro and in Vivo* , 2003, Journal of Biological Chemistry.

[2]  D. Leroith,et al.  Circulating levels of IGF-1 directly regulate bone growth and density. , 2002, The Journal of clinical investigation.

[3]  S. Mane,et al.  Insights from gene arrays on the development and growth regulation of uterine leiomyomata. , 2002, Fertility and sterility.

[4]  L. Hennighausen,et al.  Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. , 2002, Cancer research.

[5]  R. Baxter,et al.  Molecular distribution of IGF binding protein-5 in human serum. , 2002, The Journal of clinical endocrinology and metabolism.

[6]  D. Clemmons,et al.  Use of mutagenesis to probe IGF-binding protein structure/function relationships. , 2001, Endocrine reviews.

[7]  E. D. De Robertis,et al.  Neural and head induction by insulin-like growth factor signals. , 2001, Developmental cell.

[8]  Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice. , 2001, Endocrinology.

[9]  S. Mohan,et al.  Evidence that IGF-binding protein-5 functions as a growth factor. , 2001, The Journal of clinical investigation.

[10]  T. Wood,et al.  Selective alterations in organ sizes in mice with a targeted disruption of the insulin-like growth factor binding protein-2 gene. , 2000, Molecular endocrinology.

[11]  R. Baxter,et al.  Nuclear Import of Insulin-like Growth Factor-binding Protein-3 and -5 Is Mediated by the Importin β Subunit* , 2000, The Journal of Biological Chemistry.

[12]  M. Gleave,et al.  Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models. , 2000, Cancer research.

[13]  A. Renehan,et al.  Response: More About: Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF- Binding Protein-3 , 1999 .

[14]  A. Hoeflich,et al.  Overexpression of Insulin-Like Growth Factor-Binding Protein-2 in Transgenic Mice Reduces Postnatal Body Weight Gain. , 1999, Endocrinology.

[15]  Michael L. Bittner,et al.  cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. , 1999 .

[16]  E. Feldman,et al.  Regulation of Insulin-Like Growth Factor-Binding Protein-5 Expression during Schwann Cell Differentiation1. , 1999, Endocrinology.

[17]  L. Powell-Braxton,et al.  Effects of Igf1 gene deletion on postnatal growth patterns. , 1999, Endocrinology.

[18]  C. Renner,et al.  Structure of the IGF‐binding domain of the insulin‐like growth factor‐binding protein‐5 (IGFBP‐5): implications for IGF and IGF‐I receptor interactions , 1998, The EMBO journal.

[19]  David J Hunter,et al.  Circulating concentrations of insulin-like growth factor I and risk of breast cancer , 1998, The Lancet.

[20]  Stephen Twigg,et al.  Insulin-like Growth Factor (IGF)-binding Protein 5 Forms an Alternative Ternary Complex with IGFs and the Acid-labile Subunit* , 1998, The Journal of Biological Chemistry.

[21]  Meir J. Stampfer,et al.  Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study , 1998 .

[22]  A. Efstratiadis.  Genetics of mouse growth. , 1998, The International journal of developmental biology.

[23]  J. Nagy,et al.  Impaired brain development and reduced astrocyte response to injury in transgenic mice expressing IGF binding protein-1 , 1997, Brain Research.

[24]  J. Fowlkes,et al.  A rapid, non-radioactive method for the detection of insulin-like growth factor binding proteins by Western ligand blotting. , 1996, Endocrinology.

[25]  J. Ross,et al.  Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency. , 1996, The Journal of clinical investigation.

[26]  J R Florini,et al.  Growth hormone and the insulin-like growth factor system in myogenesis. , 1996, Endocrine reviews.

[27]  C. Stewart,et al.  Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism , 1996, The Journal of cell biology.

[28]  M. Lewitt,et al.  Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. , 1995, Endocrinology.

[29]  P. Cohen,et al.  The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. , 1995, Molecular endocrinology.

[30]  D. Clemmons,et al.  Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.

[31]  S. Mohan,et al.  Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: comparison with acid-ethanol treatment and C18 Sep-Pak separation. , 1995, The Journal of clinical endocrinology and metabolism.

[32]  R. Baxter,et al.  Complex formation by human insulin-like growth factor-binding protein-3 and human acid-labile subunit in growth hormone-deficient rats. , 1994, Endocrinology.

[33]  T. Wood,et al.  Distinct expression patterns of insulin-like growth factor binding proteins 2 and 5 during fetal and postnatal development. , 1994, Endocrinology.

[34]  L. Powell-Braxton,et al.  IGF-I is required for normal embryonic growth in mice. , 1993, Genes & development.

[35]  C. Bondy,et al.  Correlation between insulin-like growth factor (IGF)-binding protein 5 and IGF-I gene expression during brain development , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  P. Rotwein,et al.  A highly conserved insulin-like growth factor-binding protein (IGFBP-5) is expressed during myoblast differentiation. , 1993, The Journal of biological chemistry.

[37]  J. Baker,et al.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.

[38]  Elizabeth J. Robertson,et al.  Role of insulin-like growth factors in embryonic and postnatal growth , 1993, Cell.

[39]  D. Andress,et al.  Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. , 1992, The Journal of biological chemistry.

[40]  Yamamura Ken-ichi,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .

[41]  H. Niwa,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.

[42]  A. Efstratiadis,et al.  A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting , 1990, Nature.

[43]  R. Baxter,et al.  Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labeling. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. Binoux,et al.  Insulin-like growth factor (IGF) and IGF-binding proteins: comparison of human serum and lymph. , 1988, The Journal of clinical endocrinology and metabolism.